1. Home
  2. CVV vs CMMB Comparison

CVV vs CMMB Comparison

Compare CVV & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVV
  • CMMB
  • Stock Information
  • Founded
  • CVV 1982
  • CMMB 2004
  • Country
  • CVV United States
  • CMMB Israel
  • Employees
  • CVV N/A
  • CMMB N/A
  • Industry
  • CVV Industrial Machinery/Components
  • CMMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • CVV Technology
  • CMMB Health Care
  • Exchange
  • CVV Nasdaq
  • CMMB Nasdaq
  • Market Cap
  • CVV 20.5M
  • CMMB 22.0M
  • IPO Year
  • CVV N/A
  • CMMB N/A
  • Fundamental
  • Price
  • CVV $3.60
  • CMMB $1.13
  • Analyst Decision
  • CVV
  • CMMB Strong Buy
  • Analyst Count
  • CVV 0
  • CMMB 2
  • Target Price
  • CVV N/A
  • CMMB $8.50
  • AVG Volume (30 Days)
  • CVV 29.6K
  • CMMB 113.5K
  • Earning Date
  • CVV 08-12-2025
  • CMMB 08-20-2025
  • Dividend Yield
  • CVV N/A
  • CMMB N/A
  • EPS Growth
  • CVV N/A
  • CMMB N/A
  • EPS
  • CVV N/A
  • CMMB N/A
  • Revenue
  • CVV $30,270,000.00
  • CMMB N/A
  • Revenue This Year
  • CVV N/A
  • CMMB N/A
  • Revenue Next Year
  • CVV N/A
  • CMMB N/A
  • P/E Ratio
  • CVV N/A
  • CMMB N/A
  • Revenue Growth
  • CVV 48.85
  • CMMB N/A
  • 52 Week Low
  • CVV $2.46
  • CMMB $0.87
  • 52 Week High
  • CVV $4.80
  • CMMB $2.55
  • Technical
  • Relative Strength Index (RSI)
  • CVV 66.68
  • CMMB 35.18
  • Support Level
  • CVV $3.06
  • CMMB $1.12
  • Resistance Level
  • CVV $3.49
  • CMMB $1.23
  • Average True Range (ATR)
  • CVV 0.18
  • CMMB 0.05
  • MACD
  • CVV 0.04
  • CMMB 0.00
  • Stochastic Oscillator
  • CVV 94.41
  • CMMB 8.82

About CVV CVD Equipment Corporation

CVD Equipment Corp is engaged in the manufacturing of chemical vapor deposition equipment, customized gas control systems, the manufacturing of process equipment suitable for the synthesis of a variety of one-dimensional nanostructures and nanomaterials and a line of furnaces, all of which are used to produce semiconductors and other electronic components. The company operates through the segments of CVD Equipment, CVD materials, and Stainless Design Concepts, MesoScribe. It generates maximum revenue from the CVD Equipment segment. The CVD Equipment segment manufactures and sells chemical vapor deposition, physical vapor transport, and similar equipment. Company operates in USA, North America, Europe, Middle East and Africa, and Asia-Pacific.

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.

Share on Social Networks: